Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Question...

I think it was a matter of logistics. Wasn't he preparing for, traveling to, and participating in an institutional investors meeting. No one else but our CEO is going to release, after being screened by TPL, any statements or news releases.

Share
New Message
Please login to post a reply